查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1441341

全球生物银行市场规模、份额、成长分析（按类型、样本、应用）- 2023-2030 年产业预测

Global Biobanking Market Size, Share, Growth Analysis, By Type(Population-based Biobanks, Disease-based Biobanks), By Sample(Blood Products, Cell Lines), By Application(Drug Discovery, Genomic Research) - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球生物银行市场规模将为695亿美元，从2023年的720亿美元成长到2031年的955亿美元，预测期间（2024-2031年）复合年增长率为6.8，预计将成长%。

近年来，由于对体育、生物医学研究和个体化医疗的需求不断增长，全球生物银行市场显着增长。生物银行对于生物样本的管理和保存至关重要，支持药物开发、疾病研究和基因组学的进步。慢性病盛行率的增加以及研究所需的大规模模式收集也推动了市场的成长。另一方面，也存在一些挑战，例如道德考虑、标准挑战以及生物银行基础设施的高昂成本。

北美因其强大的研究、基础设施和医疗保健方面的高支出而成为该地区的市场领导。主要特点包括专注于扩大图案覆盖范围以及更好地结合维护和搜寻绿色图案的技术。随着精准医疗和生物标记发现需求的增加，生物银行市场预计将稳定成长。

全球生物银行市场区隔分析

全球生物银行市场的四个主要部分是生物样本库类型、样本类型、应用和区域。依类型分为学术生物库、医院生物库、人群生物库和疾病生物库。样本类型可分为生物流体、人体组织、细胞株、核酸、血液製品等。依应用不同，可分为疾病研究、再生医学、个人化医学、基因体研究、药物开发等。市场依地理位置分为北美、欧洲、亚太地区、拉丁美洲、中东和非洲。

全球生物银行市场的驱动因素

对生物银行服务的需求主要是活性化的，特别是在基因组学和个人化医疗领域。临床试验所需的大规模样本采集和慢性病盛行率的增加是推动市场成长的另外两个因素。人们日益认识到生物银行在促进科学理解、药物发现和疾病研究方面的潜力，也刺激了全球对生物银行服务的接受度。在精准医学进步的基本驱动力和生物标记发现日益重要的推动下，生物银行产业预计将继续成长。

全球生物银行市场的限制

围绕着生物样本收集和储存的伦理问题，特别是有关同意和隐私的问题，是一项重大挑战，也是主要的市场限制之一。不同生物样本库和地区之间的标准化问题会抑制资料交换和互通性，从而降低合作研究计划的有效性。另一个障碍是建造和维护生物银行基础设施的成本高昂，这对小型研究机构尤其不利。此外，考虑到长期储存样品的永续性以及样品劣化的可能性，需要严格的品管程序。

全球生物银行市场趋势

人们越来越多地使用区块链和自动化样本储存系统等最尖端科技来提高生物银行业务的安全性和效率。此外，人们越来越重视檔案样本人群的多样化并包括不同的人口群体，以提供更全面和更具代表性的研究结果。另一项关键创新是人工智慧 (AI) 和机器学习的集成，用于资料分析和解释，从而能够从储存的生物样本中获得更深入的见解。

目录

执行摘要

  • 市场概况
  • 命运之轮

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管形势
  • 波特的分析
  • 对未来中断的特殊考虑

全球生物银行市场：按类型

  • 市场概况
  • 基于人群的生物样本库
  • 基于疾病的生物样本库
  • 学术生物样本库
  • 医院生物样本库
  • 其他的

全球生物银行库市场：按样本

  • 市场概况
  • 血液製品
  • 细胞株
  • 核酸
  • 人体组织
  • 生物体液
  • 其他的

全球生物银行市场：依应用分类

  • 市场概况
  • 药物发现
  • 基因组调查
  • 个人化医疗
  • 再生医学
  • 疾病调查
  • 其他的

全球生物银行市场规模：按地区划分

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争形势

  • 前5名企业对比
  • 主要企业市场定位（2021年）
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率（2021年）

主要企业简介

  • AMS Biotechnology（Europe）Ltd.
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta, Inc.（Azenta）
  • Bay Biosciences LLC
  • BioIVT & Elevating Science
  • Boca Biolistics
  • CTI Biotech
  • Cureline Inc.
  • Firalis SA
  • Geneticist Inc.
  • Hamilton Bonaduz AG
  • Isenet Biobanking
  • Merck & Co., Inc.
  • ProteoGenex Inc.
  • Qiagen NV
  • Stemcell Holdings, Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • US Biolab Corp. Inc.
简介目录
Product Code: SQMIG35H2200

Global Biobanking Market size was valued at USD 69.5 billion in 2022 and is poised to grow from USD 72 billion in 2023 to USD 95.5 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031)

The global biobanking market has grown significantly in recent years because to the rise in sports, biomedical research, and the need for customized care. Biobanks are essential for managing and preserving biological samples, which helps advance medication development, disease research, and genomics. The increasing prevalence of chronic illnesses and the need for large-scale pattern collecting for research studies also drive market growth. On the other hand, challenging circumstances include ethical considerations, challenges related to standards, and the exorbitant cost of biobanking infrastructure.

North America is the market leader in its region because of its strong research, well-developed infrastructure, and large spending in healthcare. Important characteristics include an emphasis on expanding pattern range and combining better technology for green pattern maintenance and retrieval. The market for biobanking is expected to grow steadily as demand for precision medicine and biomarker discovery increases.

Global Biobanking Market Market Segmental Analysis

The four main segments of the global biobanking market are biobank type, sample type, application, and geography. It is separated into several categories according to kind, including academic biobanks, hospital-based biobanks, population-based biobanks, and disease-based biobanks. It is divided into two categories according to the type of sample: biofluids, human tissues, cell lines, nucleic acids, blood products, and others. It is divided into several categories according to its use, including illness research, regenerative medicine, personalized medicine, genomics, and drug development. The market is divided into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa based on geographic factors.

Drivers of the Global Biobanking Market

The need for biobanking services is mostly driven by the rise in biomedical research activities, especially in the fields of genomics and personalized medicine. The requirement for large-scale sample collection for clinical trials and the increasing prevalence of chronic diseases are two other factors driving the market's growth. Global acceptance of biobanking services is also fueled by the increased recognition of the potential of biobanks to advance scientific understanding, drug discovery, and disease research. The biobanking industry is anticipated to continue growing due to the basic drivers of precision medicine's ongoing evolution and the growing significance of biomarker discovery.

Restraints in the Global Biobanking Market Market

The ethical issues surrounding the collection and storage of biological samples, particularly those pertaining to consent and privacy, provide a substantial difficulty and are one of the primary market limitations. Standardization problems between various biobanks and geographical areas might impede data exchange and interoperability, which reduces the efficacy of cooperative research projects. Another barrier is the high expense of setting up and keeping up biobanking infrastructure, which is particularly detrimental to smaller research institutes. Furthermore, strict quality control procedures are required due to worries about the sustainability of samples that are kept for an extended period of time and the possibility of sample deterioration.

Market Trends of the Global Biobanking Market

the growing use of cutting-edge technology to improve the security and efficiency of biobanking operations, such as blockchain and automated sample storage systems. Furthermore, in order to provide more inclusive and representative research outputs, there is an increasing emphasis on diversifying stored sample populations to include a range of demographic groups. Another important innovation that is enabling greater in-depth insights from stored biological samples is the integration of artificial intelligence (AI) and machine learning for data analysis and interpretation.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Biobanking Market by Type

  • Market Overview
  • Population-based Biobanks
  • Disease-based Biobanks
  • Academic Biobanks
  • Hospital-based Biobanks
  • and Others

Global Biobanking Market by Sample

  • Market Overview
  • Blood Products
  • Cell Lines
  • Nucleic Acids
  • Human Tissues
  • Biofluids
  • and Others

Global Biobanking Market by Application

  • Market Overview
  • Drug Discovery
  • Genomic Research
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Research
  • and Others

Global Biobanking Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • AMS Biotechnology (Europe) Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ASKION GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Azenta, Inc. (Azenta)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bay Biosciences LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioIVT & Elevating Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boca Biolistics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CTI Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cureline Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Firalis SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geneticist Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Bonaduz AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Isenet Biobanking
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ProteoGenex Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen NV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Holdings, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STEMCELL Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • US Biolab Corp. Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments